Latest Breaking News On - Department of diagnostic medicine pathobiology - Page 2 : comparemela.com

K-State selects immunology professor for research fellowship

The Biosecurity Research Institute (BRI) at Kansas State University selected Immunology Professor Waithaka Mwangi as a recipient of the 2023 Marty Vanier and Bob Krause BRI Research Fellows Program.

United statesNairobi areaWaithaka mwangiBob krauseMarty vanierKansas state universityFellows programResearch fellows programCollege of veterinary medicineBiosecurity research instituteUniversity of nairobiKstate college of agricultureUs department of agricultureDepartment of diagnostic medicine pathobiologyWashington state universityImmunology professor waithaka mwangi

Tonix Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Highlights

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesLincoln parkGregory sullivanWaithaka mwangiJessica morrisSeth ledermanOlipriya dasMarseille universitPeter vozzoKansas state universityUs centers for diseaseTonix pharmaceuticalsInserm the french national institute of healthDrug administrationDevelopment centerColumbia university

Tonix Pharmaceuticals Announces Extension of Sponsored Research Agreement with Kansas State University to Develop Live-Virus Vaccine Against COVID-19

Tonix Pharmaceuticals Announces Extension of Sponsored Research Agreement with Kansas State University to Develop Live-Virus Vaccine Against COVID-19
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesWaithaka mwangiJessica morrisJ gen virolSeth ledermanOlipriya dasPeter vozzoKansas state universityTonix pharmaceuticalsWorld health organizationExchange commissionTonix pharmaceuticals holding corpDevelopment to protect againstDepartment of diagnostic medicine pathobiologyLive virus vaccine basedBovine parainfluenza virus vector

Tonix Pharmaceuticals Announces Extension of Sponsored

TNX-2300, a Live Virus Vaccine Based on a Bovine Parainfluenza Virus Vector, in Development to Protect Against COVID-19 Co-Expression of the CD40-Ligand.

United statesWaithaka mwangiJessica morrisJ gen virolSeth ledermanOlipriya dasPeter vozzoKansas state universityTonix pharmaceuticalsWorld health organizationExchange commissionTonix pharmaceuticals holding corpDevelopment to protect againstDepartment of diagnostic medicine pathobiologyLive virus vaccine basedBovine parainfluenza virus vector

Tonix Pharmaceuticals Announces Exclusive Option and Research Collaboration with Kansas State University to Develop LNP-Free mRNA Vaccines

Tonix Pharmaceuticals Announces Exclusive Option and Research Collaboration with Kansas State University to Develop LNP-Free mRNA Vaccines - read this article along with other careers information, tips and advice on BioSpace

United statesJuergen richtWaithaka mwangiJessica morrisSeth ledermanOlipriya dasPeter vozzoKansas state universityTonix pharmaceuticalsTechnology replaces the lipid nanoparticleDepartment of anatomyExchange commissionTonix pharmaceuticals incVaccine in developmentTechnology employed in currentTonix pharmaceuticals holding corp